GINUX | NRGEX | GINUX / NRGEX | |
Total Expense Ratio | 0.84 | 0.03 | 2,800% |
Annual Report Gross Expense Ratio | 1.06 | 0.69 | 154% |
Fund Existence | 10 years | 3 years | - |
Gain YTD | -2.913 | -5.220 | 56% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 136M | 9.2B | 1% |
Annual Yield % from dividends | 0.84 | 0.56 | 151% |
Returns for 1 year | 10.45 | -0.31 | -3,398% |
Returns for 3 years | 34.48 | 1.68 | 2,056% |
Returns for 5 years | -33.14 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 60.46 | 1.74 | +2.97% |
Virtus LifeSci Biotech Products ETF | |||
PBJ | 47.67 | 0.39 | +0.82% |
Invesco Food & Beverage ETF | |||
QEFA | 84.37 | 0.34 | +0.40% |
SPDR® MSCI EAFE StrategicFactors ETF | |||
IBHG | 22.30 | 0.01 | +0.04% |
iShares® iBonds® 2027 Term HY & Inc ETF | |||
BLV | 67.34 | -0.68 | -1.00% |
Vanguard Long-Term Bond ETF |